Monday was a brutal day for the Golden State Warriors, piling fresh setbacks onto an already precarious season as the February 5, 2026, NBA trade deadline approaches. First came the sobering trade obstacles for their top target, Giannis Antetokounmpo, courtesy of NBA insider Jake Fischer in The Stein Line. Then, injury news on Stephen Curry delivered another gut punch, sidelining the franchise cornerstone for at least one key game amid persistent knee issues.
Fischer highlighted significant hurdles in the Warriors’ aggressive pursuit of the two-time MVP from the Milwaukee Bucks. League sources indicate Giannis may not be as enthusiastic about joining Golden State as initially assumed. Key concerns include teaming up with an aging core (Curry at 37, plus veterans like Draymond Green) and facing backlash similar to what Kevin Durant endured for his 2016 move to the Warriors—criticism for “joining a superteam” rather than building one. While the Warriors have assembled one of the league’s strongest potential packages (youth like Jonathan Kuminga/Brandin Podziemski, multiple first-round picks, and salary matching via Green or others), Giannis’ personal buy-in remains uncertain. The Bucks continue countering offers, signaling they’re open but holding firm—meaning no deal is imminent, and the Warriors risk missing out before Thursday’s deadline.
Compounding the frustration: Curry’s right knee woes flared up again. The Warriors officially listed him with patellofemoral pain syndrome—commonly known as “runner’s knee”—a condition involving irritation and pain around the kneecap, often from overuse, age, or increased workload. ESPN’s Anthony Slater reported on February 2: “Officially listed as patellofemoral pain syndrome (runner’s knee) for Steph Curry. Out tomorrow vs. the (Philadelphia) Sixers. Getting persistent treatment on that right knee.”
Dr. Nirav Pandya, UCSF professor of orthopedic surgery, explained under Slater’s post: “Patellofemoral pain syndrome is a blanket term used to describe irritation of the structures/tissues around the knee cap. Age and increased workload are risk factors. Key for treatment is rest and physical therapy modalities.”
The issue isn’t deemed structural or season-ending—Curry underwent an MRI after aggravating it in Friday’s loss to the Detroit Pistons (exiting in the third quarter), and it’s considered day-to-day beyond the confirmed absence vs. the Sixers on Tuesday night. Coach Steve Kerr emphasized management: Returns depend on team doctor Rick Celebrini and Curry himself, with persistent treatment ongoing. No long-term prognosis has surfaced, but “runner’s knee” typically responds well to rest and PT, especially if caught early.
This timing couldn’t be worse. The Warriors are already without second-best player Jimmy Butler (season-ending ACL tear), leaving Curry as the undisputed engine. Missing him even short-term strains depth—expect more minutes for Buddy Hield, Brandin Podziemski, or others in the backcourt—while the team fights for positioning in a crowded West (currently around .500-ish in recent reports, chasing playoff spots). A prolonged absence would be catastrophic for a squad banking on one last big window with Curry.
The hope in Golden State: Use the next few days for positive developments. A breakthrough Giannis deal could reshape everything—pairing the Greek Freak with Curry (even if brief) might provide the jolt needed. Meanwhile, optimistic updates on Curry’s knee (quick return post-rest) would ease the panic. But Monday’s double whammy—trade roadblocks and injury confirmation—underscores the fragility of their contention push.
Warriors fans, this week is make-or-break. Can they land Giannis despite the doubts? Will Curry bounce back swiftly? The deadline clock is ticking—expect fireworks (or more frustration) by Thursday.
What do you think—does Curry’s “runner’s knee” sideline him longer, or is this just maintenance? And is Giannis to Golden State still realistic?